MedPath

内蒙古兰太药业有限责任公司

Ownership
-
Established
2003-04-03
Employees
-
Market Cap
-
Website
http://www.nmgltyy.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

96

NMPA:96

Drug Approvals

沙参止咳胶囊

Approval Number
国药准字Z20040034
Approval Date
Apr 20, 2021
NMPA

苁蓉益肾颗粒

Approval Number
国药准字Z20030099
Approval Date
Apr 20, 2021
NMPA

中盐牌盐藻蓝莓牛磺酸软胶囊

Approval Number
国食健注G20150661
Approval Date
Jan 7, 2021
NMPA

中盐<sup>R</sup>蜂王浆酸枣仁咀嚼片

Approval Number
国食健注G20140935
Approval Date
Sep 30, 2020
NMPA

兰太牌灵芝西洋参颗粒(草莓味)

Approval Number
国食健注G20140849
Approval Date
Jun 23, 2020
NMPA

益肝灵片

Approval Number
国药准字Z20027196
Approval Date
Mar 31, 2020
NMPA

Fenofibrate Tablets

Product Name
非诺贝特片
Approval Number
国药准字H15020186
Approval Date
Mar 31, 2020
NMPA

Yeast Tablets

Product Name
干酵母片
Approval Number
国药准字H15020757
Approval Date
Mar 31, 2020
NMPA

Paracetamol Tablets

Product Name
对乙酰氨基酚片
Approval Number
国药准字H15020199
Approval Date
Mar 31, 2020
NMPA

Ethambutol Hydrochloride Tablets

Product Name
盐酸乙胺丁醇片
Approval Number
国药准字H15020763
Approval Date
Mar 31, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 10
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.